News

Medical conditions and health habits that affect blood flow in the brain—or cerebrovascular risk factors—are associated with a subsequent diagnosis of Parkinson’s disease, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian investigators.

Scientists at Weill Cornell Medicine have developed a system that uses cancer patients’ own cells to evaluate the efficacy of treatments. The scientists used their new testbed to show that a two-drug combination potentially would benefit many patients with acute myeloid leukemia (AML).

Memorial Sloan Kettering nanotechnology researcher Dr. Daniel Heller recently worked with an artist to create nanotube-based paints that can be used to test for cancer and diabetes — and to make a new form of visual art.

A team of scientists from Weill Cornell Medicine and The Rockefeller University has illuminated the basic mechanism of Piezo proteins, which function as sensors in the body for mechanical stimuli such as touch, bladder fullness and blood pressure.

Dr. Kyu Rhee, an associate professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine, has been awarded a Physician-Scientist Institutional Award by the Burroughs Wellcome Fund.

Dr. Silvia Formenti has been awarded the 2019 Roentgen Prize for Oncology from the Italian scientific society Accademia Nazionale dei Lincei.

Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to launch a program designed to increase the number of underrepresented minority medical and graduate students, residents and postdoctoral fellows committed to careers in health equity and global health research.

Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.

Dr. Gregory F. Sonnenberg, an associate professor of microbiology and immunology in medicine in the Weill Department of Medicine’s Division of Gastroenterology and Hepatology and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine, has been named an awardee for the inaugural CRI Lloyd J. Old STAR (Scientists Taking Risks) Program by the Cancer Research Institute.

Chemical modifications that appear on some RNA transcripts may have evolved in part to help cells repair themselves after damage, and may also be a key to understanding important human diseases, according to new research from scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.

Dr. Sheila Nirenberg, the Nanette Laitman Professor in Neurology and Neuroscience and a professor of physiology and biophysics at Weill Cornell Medicine, has been named one of Crain’s inaugural Notable Women in Technology in the Greater New York City area.

Dr. Lewis Cantley has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and ovarian cancer, investigating how early-stage precancerous cells can be recognized by the immune system and targeted with preventive or therapeutic cancer vaccines.

Idiopathic pulmonary fibrosis (IPF), a fatal lung disease whose cause has long been a mystery, may be triggered by damage to mitochondria, the tiny oxygen-burning reactors that provide most of a cell’s energy needs, according to a study from scientists at Weill Cornell Medicine.

HIV epidemics are emerging and growing among female sex workers and their male clients in multiple countries in the Middle East and North Africa, and few of these epidemics have already reached their peak.

A molecular pathway known for responding to cellular stress also produces pain-inducing molecules in immune cells, according to a new study by scientists at Weill Cornell Medicine, Dana-Farber Cancer Institute, Harvard Medical School and Wake Forest University School of Medicine.

Two molecular signaling pathways underlie the cardiac defects associated with one type of the inherited disorder Noonan syndrome (NS), researchers from Masonic Medical Research Institute, Beth Israel Deaconess Medical Center and Weill Cornell Medicine find in a new study.

A newly available drug may improve the effectiveness of immunotherapy in hard-to-treat cancers of the upper urinary tract, suggests a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A new study published July 8 in the Annals of Internal Medicine demonstrates that pregnancy outcomes in the last two decades have drastically improved for patients with systemic lupus erythematosus.

A new technology devised by scientists at Weill Cornell Medicine and the New York Genome Center (NYGC) enables the measurement of gene mutations and their effects on gene activity within individual cancer cells biopsied from patients.

Early disruptions in brain cell activity may give rise to autism.